4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-24-006170
EVP R&D, Chief Medical Officer gave up 8,523 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 19,194 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/form4.xml…